Abstract
Background
Impact of body mass index (BMI) on all-cause mortality in atrial fibrillation (AF) patients remains controversial.
Methods
A total of 10,942 AF patients were prospectively enrolled and categorized into four BMI groups: underweight (BMI < 18.5 kg/m2), normal weight (BMI 18.5–24 kg/m2), overweight (BMI 24–28 kg/m2) and obesity (BMI ≥ 28 kg/m2). The primary outcome was all-cause mortality. Different Cox proportional hazards models were performed to evaluate the association between BMI and all-cause mortality.
Results
During a median follow-up of 30 months (IQR 18–48 months), 862 deaths events occurred. Compared to normal BMI, higher BMI was associated with a lower mortality risk (overweight: HR 0.70; 95% CI 0.61–0.81, P < 0.0001 and obesity: HR 0.54; 95% CI 0.44–0.67, P < 0.0001) and lower BMI was associated with a higher mortality risk (HR 2.23, 95% CI 1.67–2.97, P < 0.0001).
Conclusion
A reversed relationship between BMI and all-cause mortality in AF patients was found. Higher risk of mortality was observed in underweight patients compared to patients with a normal BMI, while overweight and obese patients had a lower risk of all-cause mortality.
Clinical trial registration
URL: http://www.chictr.org.cn/showproj.aspx?proj=5831. Unique identifier: ChiCTR-OCH-13003729.
Similar content being viewed by others
References
Morin DP, Bernard ML, Madias C, Rogers PA, Thihalolipavan S, Estes NAM (2016) The state of the art: atrial fibrillation epidemiology, prevention, and treatment. Mayo Clin Proc 91:1778–1810
Chugh SS, Havmoeller R, Narayanan K, Singh D, Rienstra M, Benjamin EJ, Gillum RF, Kim YH, McAnulty JH Jr, Zheng ZJ, Forouzanfar MH, Naghavi M, Mensah GA, Ezzati M, Murray CJ (2014) Worldwide epidemiology of atrial fibrillation: a global burden of disease 2010 study. Circulation 129:837–847
Jobs A, Schwind J, Katalinic A, Babaev V, Tilz RR, Rausch S, Thiele H, Eitel I, Eitel C (2019) Prognostic significance of atrial fibrillation in acute decompensated heart failure with reduced versus preserved ejection fraction. Clin Res Cardiol 108:74–82
Abed HS, Samuel CS, Lau DH, Kelly DJ, Royce SG, Alasady M, Mahajan R, Kuklik P, Zhang Y, Brooks AG, Nelson AJ, Worthley SG, Abhayaratna WP, Kalman JM, Wittert GA, Sanders P (2013) Obesity results in progressive atrial structural and electrical remodeling: implications for atrial fibrillation. Heart Rhythm 10:90–100
Chau K, Girerd N, Magnusson M, Lamiral Z, Bozec E, Merckle L, Leosdottir M, Bachus E, Frikha Z, Ferreira JP, Després J-P, Rossignol P, Boivin J-M, Zannad F (2018) Obesity and metabolic features associated with long-term developing diastolic dysfunction in an initially healthy population-based cohort. Clin Res Cardiol 107:887–896
Tedrow UB, Conen D, Ridker PM, Cook NR, Koplan BA, Manson JE, Buring JE, Albert CM (2010) The long- and short-term impact of elevated body mass index on the risk of new atrial fibrillation the WHS (women’s health study). J Am Coll Cardiol 55:2319–2327
Rosengren A, Hauptman PJ, Lappas G, Olsson L, Wilhelmsen L, Swedberg K (2009) Big men and atrial fibrillation: effects of body size and weight gain on risk of atrial fibrillation in men. Eur Heart J 30:1113–1120
Lavie CJ, Pandey A, Lau DH, Alpert MA, Sanders P (2017) Obesity and atrial fibrillation prevalence, pathogenesis, and prognosis: effects of weight loss and exercise. J Am Coll Cardiol 70:2022–2035
Tsang TS, Barnes ME, Miyasaka Y, Cha SS, Bailey KR, Verzosa GC, Seward JB, Gersh BJ (2008) Obesity as a risk factor for the progression of paroxysmal to permanent atrial fibrillation: a longitudinal cohort study of 21 years. Eur Heart J 29:2227–2233
Huxley RR, Lopez FL, Folsom AR, Agarwal SK, Loehr LR, Soliman EZ, Maclehose R, Konety S, Alonso A (2011) Absolute and attributable risks of atrial fibrillation in relation to optimal and borderline risk factors: the atherosclerosis risk in communities (ARIC) study. Circulation 123:1501–1508
Wong CX, Sullivan T, Sun MT, Mahajan R, Pathak RK, Middeldorp M, Twomey D, Ganesan AN, Rangnekar G, Roberts-Thomson KC, Lau DH, Sanders P (2015) Obesity and the risk of incident, post-operative, and post-ablation atrial fibrillation. JACC Clin Electrophysiol 1:139–152
Ardestani A, Hoffman HJ, Cooper HA (2010) Obesity and outcomes among patients with established atrial fibrillation. Am J Cardiol 106:369–373
Wang JYY, Zhu J, Zhang H, Shao XH, Tian L, Huang B, Yu LT, Gao X, Wang M (2014) Overweight is associated with improved survival and outcomes in patients with atrial fibrillation. Clin Res Cardiol 103:533–542
Sandhu RK, Ezekowitz J, Andersson U, Alexander JH, Granger CB, Halvorsen S, Hanna M, Hijazi Z, Jansky P, Lopes RD, L W (2016) The ‘obesity paradox’ in atrial fibrillation: observations from the ARISTOTLE (apixaban for reduction in stroke and other thromboembolic events in atrial fibrillation) trial. Eur Heart J 37:2869–2878
Proietti M, Guiducci E, Cheli P, Lip GY (2017) Is there an obesity paradox for outcomes in atrial fibrillation? A systematic review and meta-analysis of non-vitamin K antagonist oral anticoagulant trials. Stroke 48:857–866
Senoo K, Lip GY (2016) Body mass index and adverse outcomes in elderly patients with atrial fibrillation: the AMADEUS trial. Stroke 47:523–526
Pandey A, Gersh BJ, McGuire DK, Shrader P, Thomas L, Kowey PR, Mahaffey KW, Hylek E, Sun S, Burton P, Piccini J, Peterson E, Fonarow GC (2016) Association of body mass index with care and outcomes in patients with atrial fibrillation results from the ORBIT-AF registry. JACC Clin Electrophysiol 2:355–363
Inoue H, Kodani E, Atarashi H, Okumura K, Yamashita T, Origasa H (2016) Impact of body mass index on the prognosis of japanese patients with non-valvular atrial fibrillation. Am J Cardiol 118:215–221
Flegal KM, Graubard BI, Williamson DF, Cooper RS (2011) Reverse causation and illness-related weight loss in observational studies of body weight and mortality. Am J Epidemiol 173:1–9
Stokes A, Preston SH (2015) Smoking and reverse causation create an obesity paradox in cardiovascular disease. Obesity (Silver Spring). 23:2485–2490
Sattar N, Preiss D (2017) Reverse causality in cardiovascular epidemiological research: more common than imagined? Circulation 135:2369–2372
Shakiba M, Soori H, Mansournia MA, Nazari SSH, Salimi Y (2016) Adjusting for reverse causation to estimate the effect of obesity on mortality after incident heart failure in the atherosclerosis risk in communities (ARIC) study. Epidemiol Health 38:e2016025
Lawlor DA, Hart CL, Hole DJ, G. DS (2006) Reverse causality and confounding and the associations of overweight and obesity with mortality. Obesity (Silver Spring) 14:2294–2304
Global BMI Mortality Collaboration, Di Angelantonio E, Bhupathiraju ShN, Wormser D, Gao P, Kaptoge S, Berrington de Gonzalez A, Cairns BJ, Huxley R, Jackson ChL, Joshy G, Lewington S, Manson JE, Murphy N, Patel AV, Samet JM, Woodward M and Zheng W ZM, Bansal N, Barricarte A, Carter B, Cerhan JR, Smith GD, Fang X, Franco OH, Green J, Halsey J, Hildebrand JS, Jung KJ, Korda RJ, McLerran DF, Moore SC, O’Keeffe LM, Paige E, Ramond A, Reeves GK, Rolland B, Sacerdote C, Sattar N, Sofianopoulou E, Stevens J, Thun M, Ueshima H, Yang L, Yun YD, Willeit P, Banks E, Beral V, Chen Zh, Gapstur SM, Gunter MJ, Hartge P, Jee SH, Lam TH, Peto R, Potter JD, Willett WC, Thompson SG, Danesh J, Hu FB (2016) Body-mass index and all-cause mortality: individual participant-data meta-analysis of 239 prospective studies in four continents. Lancet 20:779–786
Du X, Ma C, Wu J, Li S, Ning M, Tang R, Guo X, Long D, Yu R, Sang C, Jiang C, Zhang T, Pan J, Liu X, Dong J, Lip GY, Investigators C (2016) Rationale and design of the Chinese Atrial Fibrillation Registry Study. BMC Cardiovasc Disord 16:1–7
McNamara RLBL, Drozda JP Jr, Go AS, Halperin JL, Kerr CR et al (2004) ACC/AHA key data elements and definitions for measuring the clinical management and outcomes of patients with atrial fibrillation: a Report of the American College of Cardiology/American Heart Association Task Force on Clinical Data Standards (Writing Committee to Develop Data Standards on Atrial Fibrillation). Circulation 109:3223–3243
428-2013 WT (2013) Healthy adult weight determination
Zhu W, Wan R, Liu F, Hu J, Huang L, Li J, Hong K (2016) Relation of body mass index with adverse outcomes among patients with atrial fibrillation: a meta-analysis and systematic review. J Am Heart Assoc 5:e004006
Curtis JP, Selter JG, Wang Y, Rathore SS, Jovin IS, Jadbabaie F, Kosiborod M, Portnay EL, Sokol SI, Bader F, Krumholz HM (2005) The obesity paradox: body mass index and outcomes in patients with heart failure. Arch Intern Med 165:55–61
Romero-Corral A, Montori VM, Somers VK, Korinek J, Thomas RJ, Allison TG, Mookadam F, Lopez-Jimenez F (2006) Association of bodyweight with total mortality and with cardiovascular events in coronary artery disease: a systematic review of cohort studies. Lancet 368:666–678
Costanzo P, Cleland JGF, Pellicori P, Clark AL, Hepburn D, Kilpatrick ES, Perrone-Filardi P, Zhang J, Atkin SL (2015) The obesity paradox in type 2 diabetes mellitus: relationship of body mass index to prognosis. Ann Intern Med 162:1–26
Zhang J, Begley A, Jackson R, Harrison M, Pellicori P, Clark AL, Cleland JGF (2019) Body mass index and all-cause mortality in heart failure patients with normal and reduced ventricular ejection fraction: a dose-response meta-analysis. Clin Res Cardiol 108:119–132
Stovitz SD, Banack HR, Kaufman JS (2018) Structural bias in studies of cardiovascular disease: let’s not be fooled by the “obesity paradox”. Can J Cardiol 34:540–542
Sanders P, Lau DH (2016) Mortality paradox in obesity and atrial fibrillation: true clinical phenomenon or red herring in atrial fibrillation care? JACC Clin Electrophysiol 2:364–366
Preston SHSA (2014) Obesity paradox: conditioning on disease enhances biases in estimating the mortality risks of obesity. Epidemiology 25:454–461
Boriani G, Laroche C, Diemberger I, Fantecchi E, Meeder J, Kurpesa M, Baluta MM, Proietti M, Tavazzi L, Maggioni AP, Lip GYH, Investigators E-AGPR (2018) Overweight and obesity in patients with atrial fibrillation: sex differences in 1-year outcomes in the EORP-AF general pilot registry. J Cardiovasc Electrophysiol 29:566–572
Wu S, Yang YM, Zhu J, Wan HB, Wang J, Zhang H, Shao XH (2017) Impact of age on the association between body mass index and all-cause mortality in patients with atrial fibrillation. J Nutr Health Aging 21:1125–1132
Sramko M, Wichterle D, Melenovsky V, Franekova J, Clemens M, Fukunaga M, Kautzner J (2019) Independent effect of atrial fibrillation on natriuretic peptide release. Clin Res Cardiol 108:142–149
Wang TJ, Larson MG, Levy D, Benjamin EJ, Leip EP, Wilson PW, Vasan RS (2004) Impact of obesity on plasma natriuretic peptide levels. Circulation 109:594–600
Lavie CJ, De Schutter A, Patel DA, Romero-Corral A, Artham SM, Milani RV (2012) Body composition and survival in stable coronary heart disease: impact of lean mass index and body fat in the “obesity paradox”. J Am Coll Cardiol 60:1374–1380
Dorner TE, Rieder A (2012) Obesity paradox in elderly patients with cardiovascular diseases. Int J Cardiol 155:56–65
Oktay AA, Lavie CJ, Kokkinos PF, Parto P, Pandey A, Ventura HO (2017) The interaction of cardiorespiratory fitness with obesity and the obesity paradox in cardiovascular disease. Prog Cardiovasc Dis 60:30–44
Acknowledgements
We sincerely thank all the hospitals which involved in the China-AF study.
Funding
This work was supported by the National Key Research and Development Program of China (2016YFC0900901, 2016YFC1301002), Grant from the National Science Foundation of China (81530016), and Grants from Beijing Municipal Commission of Science and Technology (D151100002215003, D151100002215004).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
Dr. Jian-Zeng Dong received honoraria from Johnson & Johnson for giving lectures. Dr. Chang-Sheng Ma received honoraria from Bristol-Myers Squibb (BMS), Pfizer, Johnson & Johnson, Boehringer-Ingelheim (BI), and Bayer for giving lectures. The other authors report no conflicts of interest.
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Wang, L., Du, X., Dong, JZ. et al. Body mass index and all-cause mortality in patients with atrial fibrillation: insights from the China atrial fibrillation registry study. Clin Res Cardiol 108, 1371–1380 (2019). https://doi.org/10.1007/s00392-019-01473-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00392-019-01473-3